Bellbrook Labs LLC
Madison, WI
- UEI
- TUY5ZNJNHMC1
- CAGE
- 46M41
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- SAM.gov registration date
- Physical address
- 1232 Fourier Dr Ste. 115, Madison, WI 53717, USA
- Website
- bellbrooklabs.com
- Founded
- 2002
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Transcreener GDP FP assay | National Institute on Drug Abuse (NIH) | $3,391 | |
| R & d- medical: biomedical (basic research) | National Cancer Institute (NIH) | $225,000 | |
| Drugs and biologicals | National Heart Lung and Blood Institute (NIH) | $93,445 | |
| Sbir phase i | National Institute of Standards and Technology | $90,000 |
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
Bellbrook Labs LLC is a limited liability company based in Madison, Wisconsin, that has been registered in SAM.gov since 2005. The company appears to be a specialized research and development organization focused on advanced biotechnology and pharmaceutical research, with a particular emphasis on developing innovative screening and detection technologies for enzyme and drug discovery applications. Their work primarily centers on creating sophisticated molecular detection systems and high-throughput screening platforms that can be applied to various biomedical research domains.
The federal grant awards received by Bellbrook Labs LLC demonstrate a sophisticated research portfolio targeting critical areas of biomedical innovation. The company has secured grants from multiple prominent federal agencies, including the National Institute of General Medical Sciences (NIGMS), National Institute of Allergy and Infectious Diseases (NIAID), and National Cancer Institute (NCI). Their projects include developing chemically induced dimerization (CID) systems for detecting enzyme products with high sensitivity, which could accelerate drug discovery processes. Notably, their research spans diverse domains such as creating universal enzymatic assay methods for histone acetyltransferases, investigating potential broad-spectrum antiviral strategies by targeting the DHHC5 acyltransferase, and exploring TREX1 antagonists for cancer immunotherapy. These grants, ranging from approximately $270,929 to unspecified amounts, showcase the company's capability to conduct advanced, targeted research with potential significant implications for medical science and therapeutic development.
Quick answers
Is Bellbrook Labs LLC registered in SAM.gov?
Yes. Bellbrook Labs LLC's SAM.gov registration is active through May 21, 2027.
What is Bellbrook Labs LLC's most recent federal award?
Bellbrook Labs LLC's most recent federal grant award is Chemically induced dimerization systems for high throughput enzyme assays (R43GM154542), from National Institute of General Medical Sciences (NIH), on September 20, 2024.
On GovTribe
See Bellbrook Labs LLC's full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors